Printer Friendly

PHOENIX LASER SYSTEMS LAUNCHES INVESTIGATION

 FREMONT, Calif. Jan. 20 /PRNewswire/ -- Phoenix Laser Systems Inc. (AMEX: PXS) announced that it has undertaken an investigation into the reasons for the dramatic decline in the price of its common stock over the past few days. There has been no change or deterioration in the fundamentals of Phoenix. Phoenix has over $9 million in cash and the clinical results of its testing of its technology continue to be positive.
 Phoenix Laser Systems Inc. is a developer of integrated laser workstations primarily for use by the medical community. The company's initial efforts have been focused on the design, development and testing of its first product, the Phoenix Ophthalmic Laser Workstation. The company's technology permits surgery designed to correct nearsightedness, farsightedness and astigmatism, as well as a large number of eye disorders which are untreatable or only partially treatable with current technology.
 -0- 1/20/93
 /CONTACT: Jon Solow of Phoenix Laser Systems, 510-249-0300/
 (PXS)


CO: Phoenix Laser Systems Inc. ST: California IN: MTC CPR SU:

GT-SG -- SF005 -- 6999 01/20/93 14:55 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 20, 1993
Words:174
Previous Article:POWER OUTAGE DELAYS DELIVERY OF THE SEATTLE TIMES
Next Article:THEY FINALLY DID IT ... FAT FREE POTATO CHIPS!
Topics:


Related Articles
PHOENIX LASER SYSTEMS INC. ACQUIRES PATENT RIGHTS FOR SURGICAL LASER APPLICATIONS
PHOENIX LASER SYSTEMS INC. RECEIVES U.S. PATENT ON OPHTHALMIC WORKSTATION
PHOENIX LASER SYSTEMS ANNOUNCES DR. JOHN W. WARNER NAMED AS A CONSULTANT
PHOENIX LASER SYSTEMS RECEIVES U.S. PATENT ON OPHTHALMIC WORKSTATION
PHOENIX LASER SYSTEMS, INC. SHIPS SURGICAL WORKSTATION TO UNIVERSITY OF SOUTH FLORIDA FOR ANIMAL AND CLINICAL TRIALS
PHOENIX LASER SYSTEMS, INC. ANNOUNCES REINSTATEMENT OF SCHIFFER VOTING TRUSTEE
ASIAN INVESTORS SUE PHOENIX LASER SYSTEMS
PHOENIX LASER SYSTEMS ACQUIRES REFRACTIVE LASER RESEARCH GROUP
PHOENIX LASER SYSTEMS ANNOUNCES AMENDED AGREEMENT TO SELL SHARES TO FOREIGN INVESTORS
COMPANY RECEIVES NOTICE FROM AMERICAN STOCK EXCHANGE OF INTENT TO DELIST SECURITIES; MANAGEMENT PLANS APPEAL

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters